INSIGHTS ON CELL & GENE MANUFACTURING AND LOGISTICS
-
![gibco 2]( "Target T Cell Isolation And Magnetic Bead Removal At High Efficiency")
Target T Cell Isolation And Magnetic Bead Removal At High EfficiencyExplore a cell processing platform using magnetic beads to support the cell therapy industry through struggles with challenges such as product quality and slow, inefficient manufacturing processes.
-
![Gibco magnetic 1]( "Streamline Cell Therapy Manufacturing With Rapid And Reliable Bead Removal")
Streamline Cell Therapy Manufacturing With Rapid And Reliable Bead RemovalExplore a Magnetic Separation System designed to enable closed, fully automated, and rapid cell isolation and bead removal, while decreasing variability in cell therapy manufacturing.
-
![Gibco magnetic 1]( "Achieving High Cell Purity In Cell Therapy Manufacturing")
Achieving High Cell Purity In Cell Therapy ManufacturingExplore one companies experience with a magnetic separation system used at a vital step in cell therapy development to improve their cell purity.
-
![Gibco Thermo 1]( "Evolve Your Processes With Clinically Proven Cell Therapy Solutions")
Evolve Your Processes With Clinically Proven Cell Therapy SolutionsExplore a portfolio of products and systems that are well suited for both autologous and allogeneic applications.
-
![Gene Therapy GettyImages-852566942]( "Accelerating The Arrival Of Immuno-Oncology 2.0")
Accelerating The Arrival Of Immuno-Oncology 2.0A new era of optimized cell therapy manufacturing is on the horizon, however, development and collaboration are needed in three key areas to overcome the challenges immuno-oncology 2.0 faces.
-
![T cells GettyImages-956478348]( "Causing A Stir In Cell Therapy Scale-Up")
Causing A Stir In Cell Therapy Scale-UpDelve into how dynamic bioreactors may offer performance enhancements over traditional static types and the methods manufacturers can apply to further optimize their bioreactor performance.
-
![Cell transfection with plasmid GettyImages-1290924802]( "Plasmid DNA Manufacturing To See Impressive Growth In Years Ahead")
Plasmid DNA Manufacturing To See Impressive Growth In Years AheadPlasmid DNA is surging as an ideal starting material for gene therapies and vaccine production. Using new market research, let’s look at key market drivers, vital roadblocks, regional analysis, and the leading players in the space.
-
![Biotech scientist looking at test tube]( "Improve Your Quantification and Contamination Detection With ddPCR™ Technology")
Improve Your Quantification and Contamination Detection With ddPCR™ TechnologyExplore solutions to help labs with quantification and biotherapeutic contaminant detection. These tools include including software that supports regulatory compliance with U.S. FDA 21 CFR Part 11 regulations.
-
![GettyImages-1170974543 imaging]( "Engineering Next-Gen Organoids With Automated Lab Workflows At #SLAS2022")
Engineering Next-Gen Organoids With Automated Lab Workflows At #SLAS2022Explore an overview of the 2022 Society for Lab Automation and Screening conference, including topics like advancements in engineering next-gen organoids and developing an automated lab workflow for 3D cell culture.
-
![Vaccine Manufacturing GettyImages-1384850913]( "Modeling The Economics Of Vaccine Manufacturing")
Modeling The Economics Of Vaccine ManufacturingHere, we describe the use of a custom-designed cost model to explore the economics of vaccine manufacturing when using different modalities.
